Lack of evidence for systemic toxicity following topical chloramphenicol use

Eye

Volumn 12, Issue 5, 1998, Pages 875-879

  Walker, S ^a,c   Diaper, C J M ^a   Bowman, R ^a   Sweeney, G ^b   Seal, D V ^a   Kirkness, C M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

^c WESTERN INFIRMARY   (United Kingdom)

Author keywords

Aplastic anaemia; Blood dyscrasias; Chloramphenicol; Drug induced myelotoxicity

Indexed keywords

ANTIBIOTIC AGENT; CHLORAMPHENICOL;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BIOACCUMULATION; BLOOD DYSCRASIA; BONE MARROW TOXICITY; CLINICAL ARTICLE; DRUG SAFETY; FEMALE; HEMATOPOIESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRESCRIPTION; RISK FACTOR; TOPICAL DRUG ADMINISTRATION; TOXICITY; UNITED KINGDOM;

EID: 0031728496     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/eye.1998.221     Document Type: Article

References (38)

1. Snilack JD, Wilson WR, Cockeria FR. Tetracyclines, chloramphenicol, erythromycin, clindamycin and metronidazole. Mayo Clin Proc 1991;66:1270-80.
2. Mauger TF. Antimicrobials. In: Mauger TF, Craig EL, editors. Havener's ocular pharmacology. 6th ed. St Louis: Mosby, 1994:274-8.
3. Leopold IH, Nichols AC, Vogel AW. Penetration of chloramphenicol into the eye. Arch Ophthalmol 1950;44:22-8.
4. Beasley H, Boltralik JJ, Baldwin HA. Chloramphenicol in aqueous humour after topical treatment. Arch Ophthalmol 1975;93:184-5.
5. Aragones JV, Enksen SP. Stable chloramphenicol solutions for ocular infections. Am J Ophthalmol 1968;60:104-6.
6. Hanna C, Massey JY, Hendrickson RD, Williamson J, Jones EM, Wilson P. Ocular penetration of chloramphenicol. Arch Ophthalmol 1978;96:1258-61.
7. Kirkness CM, Seal D, Hay J. Topical chloramphenicol: use or abuse? Eye 1995;9:vii-viii.
8. Doona M, Walsh JB. Use of chloramphenicol as a topical eye medication: time to cry halt? BMJ 1995;310:1217-8.
9. McCurdy PR. Plasma concentration of chloramphenicol and bone marrow suppression. Blood 1963;21:363-72.
10. Scott JL, Finegold SM, Belkin GA, Lawrence JS. A controlled double blind study of the haematological toxicity of chloramphenicol. N Engl J Med 1965;272:1137-12.
11. Best WR. Chloramphenicol associated blood dyscrasias: a review of cases submitted to the American Medical Association Registry. JAMA 1967;201:181-8.
12. Kucers A. Current position of chloramphenicol chemotherapy. J Antimicrob Chemother 1980;6:1-9.
13. Yunis AA. Chloramphenicol-induced bone marrow suppression. Semin Hematol 1973;10:225-34.
14. Young NS, Maciejewski J. The pathophysiology of acquired aplastic anaemia. N Engl J Med 1997;336:1365-71.
15. Rosenthal RL, Blackman A. Bone-marrow hypoplasia following use of chloramphenicol eye drops. JAMA 1965;191:148-9.
16. Carpenter G. Chloramphenicol eye-drops and marrow aplasia. Lancet 1975;ii:326-7.
17. Abrams SM, Degnan TJ, Vinciguerra V. Marrow aplasia following topical application of chloramphenicol eye ointment. Arch Intern Med 1980;140:576-7.
18. Fraunfelder FT, Bagby GC, Kelly DJ. Fatal aplastic anaemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 1982;93:356-60.
19. Issaragrissil S, Piankijagum A. Aplastic anaemia following topical administration of ophthalmic chloramphenicol: report of a case and review of the literature. J Med Assoc Thai 1985;68:309-12.
20. De Sevilla TF, Alegre J, Vallespi T, Falco V, Martinez-Vazquez JM. Adult pure red cell aplasia following topical ocular chloramphenicol. Br J Ophthalmol 1990;74:640.
21. McWhae JA, Chang J, Lipton JH. Drug-induced fatal aplastic anaemia following cataract surgery. Can J Ophthalmol 1992;27:313-5.
22. Flach AJ. Fatal aplastic anaemia following topical administration of ophthalmic chloramphenicol. Am J Ophthalmol 1982;94:420-2.
23. Fraunfelder FT, Morgan RL, Yunis AA. Blood dyscrasias and topical ophthalmic chloramphenicol. Am J Ophthalmol 1993;115:812-3.
24. Davidoff E. Aplastic anaemia and chloramphenicol. Am J Ophthalmol 1982;94:268-9.
25. The International Agranulocytosis and Aplastic Anaemia Study. Incidence of aplastic anaemia: the relevance of diagnostic criteria. Blood 1987;70:1718-21.
26. Bowen RL, Muir KR, Harriss C. Determining the incidence of aplastic anaemia using data from the Scottish record linkage system. Br J Haematol 1997;97(Suppl 1):22.
27. Wallerstein RO, Condit PK, Kasper CK, Brown JW, Morrison FR. Statewide study of chloramphenicol therapy and fatal aplastic anaemia. JAMA 1969;208:2045-50.
28. McGuinness R. Chloramphenicol eye drops and blood dyscrasia. Med J Aust 1984;383.
29. Besamusca FW, Bastiaensen LA. Blood dyscrasias and topically applied chloramphenicol in ophthalmology. Doc Ophthalmol 1986;64:87-95.
30. Hall AV, Das SS, Tabaqchali S. Is it time to stop using chloramphenicol on the eye? [letter]. BMJ 1995;311:450-1.
31. Diamond J, Leeming J. Chloramphenicol eye drops: a dangerous drug? Practitioner 1995;239:608-10.
32. McGhee CNJ, Anastas CN. Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia? Br J Ophthalmol 1996;80:182-4.
33. Ursell P. Widespread use of topical chloramphenicol. Br J Ophthalmol 1996;80:854.
34. Issaragrisil S, Kaufman DW, Young NS. The epidemiology of acquired aplastic anaemia in Thailand. Blood 1995;Suppl 1:478a.
35. Shell JW. Pharmacokinetics of topically applied drugs. Surv Ophthalmol 1982;26:207-18.
36. Zaki, I, Fitzgerald P, Haardy JG, Wilson CG. A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man. J Pharm Pharmacol 1986;38:463-6.
37. Trope GE, Lawrence JR, Hind VMD, Bunney J. Systemic absorption of topically applied chloramphenicol eyedrops. Br J Ophthalmol 1979;63:690-1.
38. Gordon-Smith EC, Marsh JCW, Geary CG. Is it time to stop using chloramphenicol on the eye? [letter] BMJ 1995;311:451.